Jialei Weng

859 total citations
35 papers, 600 citations indexed

About

Jialei Weng is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Jialei Weng has authored 35 papers receiving a total of 600 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Pulmonary and Respiratory Medicine and 12 papers in Oncology. Recurrent topics in Jialei Weng's work include Ferroptosis and cancer prognosis (8 papers), Immune cells in cancer (7 papers) and Hepatocellular Carcinoma Treatment and Prognosis (5 papers). Jialei Weng is often cited by papers focused on Ferroptosis and cancer prognosis (8 papers), Immune cells in cancer (7 papers) and Hepatocellular Carcinoma Treatment and Prognosis (5 papers). Jialei Weng collaborates with scholars based in China, United States and Ethiopia. Jialei Weng's co-authors include Chenhao Zhou, Ning Ren, Qiang Zhou, Ying‐Hao Shen, Lei Han, Tongke Chen, Qiongzhu Dong, Xiaokun Lin, Minghao Xu and Manar Atyah and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Jialei Weng

33 papers receiving 597 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jialei Weng China	12	297	190	157	152	105	35	600
Serena De Matteis Italy	13	282 0.9×	178 0.9×	162 1.0×	119 0.8×	104 1.0×	34	658
Guangyan Zhangyuan China	13	349 1.2×	219 1.2×	113 0.7×	97 0.6×	87 0.8×	16	549
Marco Seehawer United States	6	242 0.8×	152 0.8×	144 0.9×	97 0.6×	52 0.5×	8	512
Guang-Ang Tian China	13	324 1.1×	180 0.9×	166 1.1×	129 0.8×	53 0.5×	20	582
Yurong Zhang China	11	413 1.4×	153 0.8×	199 1.3×	135 0.9×	57 0.5×	32	656
Tongyue Zhang China	16	418 1.4×	264 1.4×	189 1.2×	136 0.9×	51 0.5×	36	736
Wubin Zheng China	9	325 1.1×	262 1.4×	193 1.2×	165 1.1×	43 0.4×	12	618
Yibin Ren China	12	365 1.2×	163 0.9×	149 0.9×	85 0.6×	90 0.9×	13	531
Laura Antonucci Italy	14	446 1.5×	120 0.6×	209 1.3×	101 0.7×	118 1.1×	21	746
Chuanyong Zhang China	13	382 1.3×	231 1.2×	156 1.0×	125 0.8×	45 0.4×	25	630

Countries citing papers authored by Jialei Weng

Since Specialization

Citations

This map shows the geographic impact of Jialei Weng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jialei Weng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jialei Weng more than expected).

Fields of papers citing papers by Jialei Weng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jialei Weng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jialei Weng. The network helps show where Jialei Weng may publish in the future.

Co-authorship network of co-authors of Jialei Weng

This figure shows the co-authorship network connecting the top 25 collaborators of Jialei Weng. A scholar is included among the top collaborators of Jialei Weng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jialei Weng. Jialei Weng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Weng, Jialei, Feng Ju, Ningbo Fan, et al.. (2025). Single-cell insights into tumor microenvironment heterogeneity and plasticity: transforming precision therapy in gastrointestinal cancers. Journal of Experimental & Clinical Cancer Research. 44(1). 314–314.

Weng, Jialei, Mincheng Yu, Qiang Yu, et al.. (2025). Galectin-4 drives anti-PD-L1/BVZ resistance by regulating metabolic adaptation and tumour-associated neutrophils in hepatocellular carcinoma. Gut. 75(3). 620–634. 1 indexed citations

Ju, Feng, Jialei Weng, Ningbo Fan, et al.. (2025). AKR1C3 enhances radioresistance in esophageal adenocarcinoma via inhibiting ferroptosis through suppressing TRIM21-mediated ubiquitination of HSPA5. Cell Death and Disease. 16(1). 483–483. 1 indexed citations

Liu, Zhenkun, et al.. (2024). AKAP12 positive fibroblast determines immunosuppressive contexture and immunotherapy response in patients with TNBC by promoting macrophage M2 polarization. Journal for ImmunoTherapy of Cancer. 12(10). e009877–e009877. 9 indexed citations

Weng, Jialei, Zheng Wang, Zhiqiu Hu, et al.. (2024). Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy. Cancer Research. 84(11). 1817–1833. 18 indexed citations

Yang, Shiguang, Min Xu, Jialei Weng, et al.. (2024). WWOX tuning of oleic acid signaling orchestrates immunosuppressive macrophage polarization and sensitizes hepatocellular carcinoma to immunotherapy. Journal for ImmunoTherapy of Cancer. 12(11). e010422–e010422. 6 indexed citations

Xu, Wenxin, Jialei Weng, Minghao Xu, et al.. (2024). Chemokine CCL21 determines immunotherapy response in hepatocellular carcinoma by affecting neutrophil polarization. Cancer Immunology Immunotherapy. 73(3). 56–56. 8 indexed citations

Li, Qingli, Chenhao Zhou, Zhiqiu Hu, et al.. (2023). Hepatocellular carcinoma histopathological images grading with a novel attention-sharing hybrid network based on multi-feature fusion. Biomedical Signal Processing and Control. 86. 105126–105126. 8 indexed citations

Weng, Jialei, Shaoqing Liu, Qiang Zhou, et al.. (2023). Intratumoral PPT1-positive macrophages determine immunosuppressive contexture and immunotherapy response in hepatocellular carcinoma. Journal for ImmunoTherapy of Cancer. 11(6). e006655–e006655. 32 indexed citations

10.

Zhou, Chenhao, Jialei Weng, Chunxiao Liu, et al.. (2023). Disruption of SLFN11 Deficiency–Induced CCL2 Signaling and Macrophage M2 Polarization Potentiates Anti–PD-1 Therapy Efficacy in Hepatocellular Carcinoma. Gastroenterology. 164(7). 1261–1278. 76 indexed citations

11.

Zhou, Chenhao, Jialei Weng, Shaoqing Liu, et al.. (2023). Whole-exome sequencing reveals the metastatic potential of hepatocellular carcinoma from the perspective of tumor and circulating tumor DNA. Hepatology International. 17(6). 1461–1476. 3 indexed citations

12.

Weng, Jialei, Minghao Xu, Qiang Zhou, et al.. (2023). Functions of Key Enzymes of Glycolytic Metabolism in Tumor Microenvironment. Cellular Reprogramming. 25(3). 91–98. 10 indexed citations

13.

Atyah, Manar, Chenhao Zhou, Qiang Zhou, et al.. (2022). The Age-Specific Features and Clinical Significance of NRF2 and MAPK10 Expression in HCC Patients. SHILAP Revista de lepidopterología. 7 indexed citations

14.

Yi, Yong, Bao‐Ye Sun, Jialei Weng, et al.. (2022). Lenvatinib plus anti-PD-1 therapy represents a feasible conversion resection strategy for patients with initially unresectable hepatocellular carcinoma: A retrospective study. Frontiers in Oncology. 12. 1046584–1046584. 21 indexed citations

15.

Zhou, Qiang, Yirui Yin, Mincheng Yu, et al.. (2022). GTPBP4 promotes hepatocellular carcinoma progression and metastasis via the PKM2 dependent glucose metabolism. Redox Biology. 56. 102458–102458. 55 indexed citations

16.

Xu, Minghao, Chenhao Zhou, Jialei Weng, et al.. (2022). Tumor associated macrophages-derived exosomes facilitate hepatocellular carcinoma malignance by transferring lncMMPA to tumor cells and activating glycolysis pathway. Journal of Experimental & Clinical Cancer Research. 41(1). 253–253. 106 indexed citations

17.

Zhou, Chenhao, Jialei Weng, Yuan Gao, et al.. (2022). A Novel mRNA Signature Related to Immunity to Predict Survival and Immunotherapy Response in Hepatocellular Carcinoma. Journal of Clinical and Translational Hepatology. 10(5). 925–938. 2 indexed citations

18.

Weng, Jialei, Chenhao Zhou, Qiang Zhou, et al.. (2021). Development and Validation of a Metabolic Gene-Based Prognostic Signature for Hepatocellular Carcinoma. SHILAP Revista de lepidopterología. Volume 8. 193–209. 5 indexed citations

19.

Weng, Jialei, Manar Atyah, Chenhao Zhou, & Ning Ren. (2020). Prospects and challenges of circulating tumor DNA in precision medicine of hepatocellular carcinoma. Clinical and Experimental Medicine. 20(3). 329–337. 13 indexed citations

20.

Weng, Jialei, Manar Atyah, Chenhao Zhou, & Ning Ren. (2019). Progress in quantitative technique of circulating cell free DNA and its role in cancer diagnosis and prognosis. Cancer Genetics. 239. 75–84. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact